nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0746	0.213	CiPCiCtD
Prednisolone—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0718	0.205	CiPCiCtD
Prednisolone—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0718	0.205	CiPCiCtD
Prednisolone—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.0694	0.198	CiPCiCtD
Prednisolone—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.0634	0.181	CiPCiCtD
Prednisolone—Methylprednisolone—multiple sclerosis	0.0524	0.206	CrCtD
Prednisolone—Dexamethasone—multiple sclerosis	0.0516	0.203	CrCtD
Prednisolone—Betamethasone—multiple sclerosis	0.0516	0.203	CrCtD
Prednisolone—Triamcinolone—multiple sclerosis	0.0504	0.199	CrCtD
Prednisolone—Prednisone—multiple sclerosis	0.0479	0.188	CrCtD
Prednisolone—NR3C2—Betamethasone—multiple sclerosis	0.0261	0.177	CbGbCtD
Prednisolone—SERPINA6—Triamcinolone—multiple sclerosis	0.0215	0.145	CbGbCtD
Prednisolone—NR3C2—Dexamethasone—multiple sclerosis	0.0152	0.103	CbGbCtD
Prednisolone—NR3C1—Methylprednisolone—multiple sclerosis	0.0132	0.0897	CbGbCtD
Prednisolone—NR3C1—Triamcinolone—multiple sclerosis	0.01	0.068	CbGbCtD
Prednisolone—NR3C1—Betamethasone—multiple sclerosis	0.0086	0.0583	CbGbCtD
Prednisolone—NR3C1—Prednisone—multiple sclerosis	0.00802	0.0543	CbGbCtD
Prednisolone—SLCO1A2—Prednisone—multiple sclerosis	0.00691	0.0468	CbGbCtD
Prednisolone—NR3C1—Dexamethasone—multiple sclerosis	0.005	0.0339	CbGbCtD
Prednisolone—SLCO1A2—Dexamethasone—multiple sclerosis	0.00431	0.0292	CbGbCtD
Prednisolone—CYP2A6—Dexamethasone—multiple sclerosis	0.00349	0.0237	CbGbCtD
Prednisolone—SLCO1A2—Methotrexate—multiple sclerosis	0.00347	0.0235	CbGbCtD
Prednisolone—ABCB1—Methylprednisolone—multiple sclerosis	0.00308	0.0209	CbGbCtD
Prednisolone—CYP3A4—Fingolimod—multiple sclerosis	0.00286	0.0194	CbGbCtD
Prednisolone—Exemestane—Methylprednisolone—multiple sclerosis	0.00281	0.0151	CrCrCtD
Prednisolone—Exemestane—Prednisone—multiple sclerosis	0.00257	0.0138	CrCrCtD
Prednisolone—ABCB1—Mitoxantrone—multiple sclerosis	0.00225	0.0152	CbGbCtD
Prednisolone—ABCB1—Betamethasone—multiple sclerosis	0.002	0.0136	CbGbCtD
Prednisolone—Potassium Canrenoate—Prednisone—multiple sclerosis	0.00194	0.0104	CrCrCtD
Prednisolone—Ciclesonide—Methylprednisolone—multiple sclerosis	0.00187	0.01	CrCrCtD
Prednisolone—ABCB1—Prednisone—multiple sclerosis	0.00187	0.0127	CbGbCtD
Prednisolone—CYP3A4—Methylprednisolone—multiple sclerosis	0.00185	0.0125	CbGbCtD
Prednisolone—Medrysone—Methylprednisolone—multiple sclerosis	0.0018	0.00965	CrCrCtD
Prednisolone—Ciclesonide—Prednisone—multiple sclerosis	0.00171	0.00916	CrCrCtD
Prednisolone—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00167	0.00898	CrCrCtD
Prednisolone—Flurandrenolide—Betamethasone—multiple sclerosis	0.00164	0.00884	CrCrCtD
Prednisolone—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00164	0.00884	CrCrCtD
Prednisolone—Hydrocortamate—Methylprednisolone—multiple sclerosis	0.00156	0.0084	CrCrCtD
Prednisolone—Cortisone acetate—Methylprednisolone—multiple sclerosis	0.00152	0.00814	CrCrCtD
Prednisolone—Testolactone—Methylprednisolone—multiple sclerosis	0.00147	0.0079	CrCrCtD
Prednisolone—Clocortolone—Methylprednisolone—multiple sclerosis	0.00147	0.0079	CrCrCtD
Prednisolone—Prednicarbate—Methylprednisolone—multiple sclerosis	0.00147	0.0079	CrCrCtD
Prednisolone—Clocortolone—Dexamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Beclomethasone—Betamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Prednicarbate—Betamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Prednicarbate—Dexamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Testolactone—Dexamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Testolactone—Betamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Clocortolone—Betamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Beclomethasone—Dexamethasone—multiple sclerosis	0.00145	0.00777	CrCrCtD
Prednisolone—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00143	0.00767	CrCrCtD
Prednisolone—Hydrocortamate—Prednisone—multiple sclerosis	0.00143	0.00766	CrCrCtD
Prednisolone—Beclomethasone—Triamcinolone—multiple sclerosis	0.00141	0.00759	CrCrCtD
Prednisolone—Prednicarbate—Triamcinolone—multiple sclerosis	0.00141	0.00759	CrCrCtD
Prednisolone—Testolactone—Triamcinolone—multiple sclerosis	0.00141	0.00759	CrCrCtD
Prednisolone—Clocortolone—Triamcinolone—multiple sclerosis	0.00141	0.00759	CrCrCtD
Prednisolone—Fluocortolone—Betamethasone—multiple sclerosis	0.00141	0.00755	CrCrCtD
Prednisolone—Fluocortolone—Dexamethasone—multiple sclerosis	0.00141	0.00755	CrCrCtD
Prednisolone—CYP3A4—Triamcinolone—multiple sclerosis	0.0014	0.00948	CbGbCtD
Prednisolone—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.00139	0.00746	CrCrCtD
Prednisolone—Alclometasone—Methylprednisolone—multiple sclerosis	0.00139	0.00746	CrCrCtD
Prednisolone—Cortisone acetate—Prednisone—multiple sclerosis	0.00138	0.00743	CrCrCtD
Prednisolone—Fluocortolone—Triamcinolone—multiple sclerosis	0.00137	0.00738	CrCrCtD
Prednisolone—Alclometasone—Dexamethasone—multiple sclerosis	0.00137	0.00734	CrCrCtD
Prednisolone—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00137	0.00734	CrCrCtD
Prednisolone—Alclometasone—Betamethasone—multiple sclerosis	0.00137	0.00734	CrCrCtD
Prednisolone—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00137	0.00734	CrCrCtD
Prednisolone—Budesonide—Methylprednisolone—multiple sclerosis	0.00135	0.00726	CrCrCtD
Prednisolone—CYP3A4—Mitoxantrone—multiple sclerosis	0.00135	0.00913	CbGbCtD
Prednisolone—Testolactone—Prednisone—multiple sclerosis	0.00134	0.00721	CrCrCtD
Prednisolone—Prednicarbate—Prednisone—multiple sclerosis	0.00134	0.00721	CrCrCtD
Prednisolone—Alclometasone—Triamcinolone—multiple sclerosis	0.00134	0.00717	CrCrCtD
Prednisolone—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00134	0.00717	CrCrCtD
Prednisolone—Budesonide—Betamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Amcinonide—Betamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Fluoxymesterone—Dexamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Fluoxymesterone—Betamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Amcinonide—Dexamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Budesonide—Dexamethasone—multiple sclerosis	0.00133	0.00714	CrCrCtD
Prednisolone—Diflorasone—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Fludrocortisone—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Flunisolide—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Desonide—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Prednisone—Methylprednisolone—multiple sclerosis	0.00132	0.00707	CrCrCtD
Prednisolone—Fluocortolone—Prednisone—multiple sclerosis	0.0013	0.007	CrCrCtD
Prednisolone—Budesonide—Triamcinolone—multiple sclerosis	0.0013	0.00698	CrCrCtD
Prednisolone—Amcinonide—Triamcinolone—multiple sclerosis	0.0013	0.00698	CrCrCtD
Prednisolone—Fluoxymesterone—Triamcinolone—multiple sclerosis	0.0013	0.00698	CrCrCtD
Prednisolone—Flunisolide—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Flunisolide—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Fludrocortisone—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Fludrocortisone—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Desonide—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Clobetasol propionate—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Desonide—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Diflorasone—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Prednisone—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Diflorasone—Betamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Prednisone—Dexamethasone—multiple sclerosis	0.0013	0.00696	CrCrCtD
Prednisolone—Paramethasone—Methylprednisolone—multiple sclerosis	0.00128	0.00689	CrCrCtD
Prednisolone—Alclometasone—Prednisone—multiple sclerosis	0.00127	0.00681	CrCrCtD
Prednisolone—Diflorasone—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Fludrocortisone—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Prednisone—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Flunisolide—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Desonide—Triamcinolone—multiple sclerosis	0.00127	0.0068	CrCrCtD
Prednisolone—Paramethasone—Dexamethasone—multiple sclerosis	0.00126	0.00678	CrCrCtD
Prednisolone—Paramethasone—Betamethasone—multiple sclerosis	0.00126	0.00678	CrCrCtD
Prednisolone—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00125	0.00673	CrCrCtD
Prednisolone—Paramethasone—Triamcinolone—multiple sclerosis	0.00123	0.00663	CrCrCtD
Prednisolone—Amcinonide—Prednisone—multiple sclerosis	0.00123	0.00662	CrCrCtD
Prednisolone—Budesonide—Prednisone—multiple sclerosis	0.00123	0.00662	CrCrCtD
Prednisolone—Desoximetasone—Betamethasone—multiple sclerosis	0.00123	0.00662	CrCrCtD
Prednisolone—Desoximetasone—Dexamethasone—multiple sclerosis	0.00123	0.00662	CrCrCtD
Prednisolone—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00122	0.00657	CrCrCtD
Prednisolone—Mometasone—Methylprednisolone—multiple sclerosis	0.00122	0.00657	CrCrCtD
Prednisolone—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00122	0.00657	CrCrCtD
Prednisolone—Loteprednol—Methylprednisolone—multiple sclerosis	0.00122	0.00657	CrCrCtD
Prednisolone—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00122	0.00657	CrCrCtD
Prednisolone—Desoximetasone—Triamcinolone—multiple sclerosis	0.0012	0.00647	CrCrCtD
Prednisolone—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Loteprednol—Dexamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Loteprednol—Betamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Fluorometholone—Dexamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Fluorometholone—Betamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Triamcinolone—Betamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Mometasone—Dexamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Triamcinolone—Dexamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Mometasone—Betamethasone—multiple sclerosis	0.0012	0.00646	CrCrCtD
Prednisolone—Clobetasol propionate—Prednisone—multiple sclerosis	0.0012	0.00645	CrCrCtD
Prednisolone—Diflorasone—Prednisone—multiple sclerosis	0.0012	0.00645	CrCrCtD
Prednisolone—Fludrocortisone—Prednisone—multiple sclerosis	0.0012	0.00645	CrCrCtD
Prednisolone—Desonide—Prednisone—multiple sclerosis	0.0012	0.00645	CrCrCtD
Prednisolone—Flunisolide—Prednisone—multiple sclerosis	0.0012	0.00645	CrCrCtD
Prednisolone—CYP3A4—Betamethasone—multiple sclerosis	0.0012	0.00814	CbGbCtD
Prednisolone—Rimexolone—Methylprednisolone—multiple sclerosis	0.00119	0.00642	CrCrCtD
Prednisolone—Betamethasone—Methylprednisolone—multiple sclerosis	0.00119	0.00642	CrCrCtD
Prednisolone—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00119	0.00642	CrCrCtD
Prednisolone—Betamethasone—Dexamethasone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Rimexolone—Dexamethasone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Rimexolone—Betamethasone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Dexamethasone—Betamethasone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Loteprednol—Triamcinolone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Fluorometholone—Triamcinolone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Mometasone—Triamcinolone—multiple sclerosis	0.00118	0.00631	CrCrCtD
Prednisolone—Paramethasone—Prednisone—multiple sclerosis	0.00117	0.00629	CrCrCtD
Prednisolone—Methyltestosterone—Prednisone—multiple sclerosis	0.00117	0.00629	CrCrCtD
Prednisolone—ABCB1—Dexamethasone—multiple sclerosis	0.00117	0.0079	CbGbCtD
Prednisolone—Rimexolone—Triamcinolone—multiple sclerosis	0.00115	0.00617	CrCrCtD
Prednisolone—Betamethasone—Triamcinolone—multiple sclerosis	0.00115	0.00617	CrCrCtD
Prednisolone—Dexamethasone—Triamcinolone—multiple sclerosis	0.00115	0.00617	CrCrCtD
Prednisolone—Desoximetasone—Prednisone—multiple sclerosis	0.00114	0.00614	CrCrCtD
Prednisolone—Methylprednisolone—Betamethasone—multiple sclerosis	0.00112	0.00604	CrCrCtD
Prednisolone—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00112	0.00604	CrCrCtD
Prednisolone—CYP3A4—Prednisone—multiple sclerosis	0.00112	0.00758	CbGbCtD
Prednisolone—Loteprednol—Prednisone—multiple sclerosis	0.00112	0.00599	CrCrCtD
Prednisolone—Fluorometholone—Prednisone—multiple sclerosis	0.00112	0.00599	CrCrCtD
Prednisolone—Triamcinolone—Prednisone—multiple sclerosis	0.00112	0.00599	CrCrCtD
Prednisolone—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00112	0.00599	CrCrCtD
Prednisolone—Mometasone—Prednisone—multiple sclerosis	0.00112	0.00599	CrCrCtD
Prednisolone—Methylprednisolone—Triamcinolone—multiple sclerosis	0.0011	0.0059	CrCrCtD
Prednisolone—Dexamethasone—Prednisone—multiple sclerosis	0.00109	0.00586	CrCrCtD
Prednisolone—Rimexolone—Prednisone—multiple sclerosis	0.00109	0.00586	CrCrCtD
Prednisolone—Betamethasone—Prednisone—multiple sclerosis	0.00109	0.00586	CrCrCtD
Prednisolone—Hydrocortisone—Methylprednisolone—multiple sclerosis	0.00107	0.00577	CrCrCtD
Prednisolone—Hydrocortisone—Betamethasone—multiple sclerosis	0.00106	0.00568	CrCrCtD
Prednisolone—Hydrocortisone—Dexamethasone—multiple sclerosis	0.00106	0.00568	CrCrCtD
Prednisolone—Methylprednisolone—Prednisone—multiple sclerosis	0.00104	0.0056	CrCrCtD
Prednisolone—Hydrocortisone—Triamcinolone—multiple sclerosis	0.00103	0.00554	CrCrCtD
Prednisolone—Hydrocortisone—Prednisone—multiple sclerosis	0.00098	0.00526	CrCrCtD
Prednisolone—ABCB1—Methotrexate—multiple sclerosis	0.000937	0.00635	CbGbCtD
Prednisolone—CYP3A4—Dexamethasone—multiple sclerosis	0.000698	0.00473	CbGbCtD
Prednisolone—NR3C1—nerve—multiple sclerosis	0.000165	0.0689	CbGeAlD
Prednisolone—NR3C2—brainstem—multiple sclerosis	0.000132	0.0551	CbGeAlD
Prednisolone—NR3C2—retina—multiple sclerosis	0.000128	0.0532	CbGeAlD
Prednisolone—NR3C2—medulla oblongata—multiple sclerosis	9.22e-05	0.0384	CbGeAlD
Prednisolone—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	8.84e-05	0.0319	CbGpPWpGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	8.5e-05	0.0306	CbGpPWpGaD
Prednisolone—SERPINA6—nervous system—multiple sclerosis	8.48e-05	0.0354	CbGeAlD
Prednisolone—NR3C2—midbrain—multiple sclerosis	8.43e-05	0.0351	CbGeAlD
Prednisolone—NR3C2—spinal cord—multiple sclerosis	8.22e-05	0.0343	CbGeAlD
Prednisolone—SERPINA6—central nervous system—multiple sclerosis	8.17e-05	0.034	CbGeAlD
Prednisolone—SERPINA6—cerebellum—multiple sclerosis	7.98e-05	0.0333	CbGeAlD
Prednisolone—SLCO1A2—medulla oblongata—multiple sclerosis	7.9e-05	0.0329	CbGeAlD
Prednisolone—SLCO1A2—midbrain—multiple sclerosis	7.22e-05	0.0301	CbGeAlD
Prednisolone—NR3C1—brainstem—multiple sclerosis	7.09e-05	0.0296	CbGeAlD
Prednisolone—SLCO1A2—spinal cord—multiple sclerosis	7.05e-05	0.0294	CbGeAlD
Prednisolone—CYP2A6—cerebellum—multiple sclerosis	6.95e-05	0.029	CbGeAlD
Prednisolone—NR3C2—nervous system—multiple sclerosis	6.93e-05	0.0289	CbGeAlD
Prednisolone—NR3C2—central nervous system—multiple sclerosis	6.67e-05	0.0278	CbGeAlD
Prednisolone—NR3C2—cerebellum—multiple sclerosis	6.52e-05	0.0272	CbGeAlD
Prednisolone—SERPINA6—brain—multiple sclerosis	6.48e-05	0.027	CbGeAlD
Prednisolone—CYP2A6—Fluoropyrimidine Activity—RRM1—multiple sclerosis	6.19e-05	0.0223	CbGpPWpGaD
Prednisolone—NR3C2—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	5.94e-05	0.0214	CbGpPWpGaD
Prednisolone—SLCO1A2—nervous system—multiple sclerosis	5.94e-05	0.0248	CbGeAlD
Prednisolone—Betamethasone—PGR—multiple sclerosis	5.83e-05	0.261	CrCbGaD
Prednisolone—SLCO1A2—central nervous system—multiple sclerosis	5.72e-05	0.0238	CbGeAlD
Prednisolone—NR3C2—ACE Inhibitor Pathway—TGFB1—multiple sclerosis	5.67e-05	0.0204	CbGpPWpGaD
Prednisolone—CYP2A6—brain—multiple sclerosis	5.65e-05	0.0235	CbGeAlD
Prednisolone—SLCO1A2—Transport of organic anions—ALB—multiple sclerosis	5.61e-05	0.0202	CbGpPWpGaD
Prednisolone—SLCO1A2—cerebellum—multiple sclerosis	5.59e-05	0.0233	CbGeAlD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	5.35e-05	0.0193	CbGpPWpGaD
Prednisolone—NR3C2—brain—multiple sclerosis	5.29e-05	0.0221	CbGeAlD
Prednisolone—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	5.08e-05	0.0183	CbGpPWpGaD
Prednisolone—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	5.08e-05	0.0183	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	5.07e-05	0.0183	CbGpPWpGaD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	5.07e-05	0.0183	CbGpPWpGaD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	5e-05	0.018	CbGpPWpGaD
Prednisolone—CYP2A6—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	5e-05	0.018	CbGpPWpGaD
Prednisolone—NR3C1—medulla oblongata—multiple sclerosis	4.94e-05	0.0206	CbGeAlD
Prednisolone—Triamcinolone—BCHE—multiple sclerosis	4.88e-05	0.219	CrCbGaD
Prednisolone—NR3C2—Generic Transcription Pathway—ZNF746—multiple sclerosis	4.87e-05	0.0175	CbGpPWpGaD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	4.75e-05	0.0171	CbGpPWpGaD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	4.75e-05	0.0171	CbGpPWpGaD
Prednisolone—SLCO1A2—brain—multiple sclerosis	4.54e-05	0.0189	CbGeAlD
Prednisolone—NR3C1—midbrain—multiple sclerosis	4.52e-05	0.0188	CbGeAlD
Prednisolone—NR3C1—spinal cord—multiple sclerosis	4.41e-05	0.0184	CbGeAlD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	4.37e-05	0.0158	CbGpPWpGaD
Prednisolone—SLCO1A2—Recycling of bile acids and salts—ALB—multiple sclerosis	4.16e-05	0.015	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	4.11e-05	0.0148	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	4.11e-05	0.0148	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	3.79e-05	0.0136	CbGpPWpGaD
Prednisolone—NR3C1—nervous system—multiple sclerosis	3.72e-05	0.0155	CbGeAlD
Prednisolone—Progesterone—PGR—multiple sclerosis	3.71e-05	0.166	CrCbGaD
Prednisolone—ABCB1—retina—multiple sclerosis	3.66e-05	0.0153	CbGeAlD
Prednisolone—NR3C1—central nervous system—multiple sclerosis	3.58e-05	0.0149	CbGeAlD
Prednisolone—NR3C1—cerebellum—multiple sclerosis	3.5e-05	0.0146	CbGeAlD
Prednisolone—Dexamethasone—PGR—multiple sclerosis	3.39e-05	0.152	CrCbGaD
Prednisolone—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	3.35e-05	0.0121	CbGpPWpGaD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	2.99e-05	0.0108	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	2.93e-05	0.0105	CbGpPWpGaD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	2.93e-05	0.0105	CbGpPWpGaD
Prednisolone—NR3C1—brain—multiple sclerosis	2.84e-05	0.0118	CbGeAlD
Prednisolone—CYP3A4—nervous system—multiple sclerosis	2.81e-05	0.0117	CbGeAlD
Prednisolone—CYP3A4—central nervous system—multiple sclerosis	2.71e-05	0.0113	CbGeAlD
Prednisolone—ABCB1—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	2.71e-05	0.00975	CbGpPWpGaD
Prednisolone—ABCB1—medulla oblongata—multiple sclerosis	2.65e-05	0.011	CbGeAlD
Prednisolone—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	2.65e-05	0.00954	CbGpPWpGaD
Prednisolone—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	2.59e-05	0.00933	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	2.51e-05	0.00905	CbGpPWpGaD
Prednisolone—ABCB1—midbrain—multiple sclerosis	2.42e-05	0.0101	CbGeAlD
Prednisolone—ABCB1—spinal cord—multiple sclerosis	2.36e-05	0.00984	CbGeAlD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC15A2—multiple sclerosis	2.34e-05	0.00845	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—ZNF746—multiple sclerosis	2.34e-05	0.00844	CbGpPWpGaD
Prednisolone—Muscular weakness—Betamethasone—multiple sclerosis	2.33e-05	0.000417	CcSEcCtD
Prednisolone—Erythema—Mitoxantrone—multiple sclerosis	2.32e-05	0.000416	CcSEcCtD
Prednisolone—Osteoarthritis—Prednisone—multiple sclerosis	2.3e-05	0.000411	CcSEcCtD
Prednisolone—Urticaria—Cladribine—multiple sclerosis	2.29e-05	0.00041	CcSEcCtD
Prednisolone—Weight increased—Triamcinolone—multiple sclerosis	2.29e-05	0.00041	CcSEcCtD
Prednisolone—Weight increased—Methylprednisolone—multiple sclerosis	2.28e-05	0.000409	CcSEcCtD
Prednisolone—Affect lability—Prednisone—multiple sclerosis	2.26e-05	0.000405	CcSEcCtD
Prednisolone—Sweating increased—Dexamethasone—multiple sclerosis	2.22e-05	0.000398	CcSEcCtD
Prednisolone—Sweating increased—Betamethasone—multiple sclerosis	2.22e-05	0.000398	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	2.22e-05	0.00801	CbGpPWpGaD
Prednisolone—Thrombophlebitis—Methotrexate—multiple sclerosis	2.22e-05	0.000397	CcSEcCtD
Prednisolone—Acute coronary syndrome—Triamcinolone—multiple sclerosis	2.21e-05	0.000396	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—multiple sclerosis	2.21e-05	0.000395	CcSEcCtD
Prednisolone—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	2.21e-05	0.000395	CcSEcCtD
Prednisolone—Neuropathy peripheral—Triamcinolone—multiple sclerosis	2.2e-05	0.000393	CcSEcCtD
Prednisolone—Myocardial infarction—Triamcinolone—multiple sclerosis	2.2e-05	0.000393	CcSEcCtD
Prednisolone—Myocardial infarction—Methylprednisolone—multiple sclerosis	2.19e-05	0.000392	CcSEcCtD
Prednisolone—Neuropathy peripheral—Methylprednisolone—multiple sclerosis	2.19e-05	0.000392	CcSEcCtD
Prednisolone—Vision blurred—Mitoxantrone—multiple sclerosis	2.19e-05	0.000392	CcSEcCtD
Prednisolone—Cardiac arrest—Prednisone—multiple sclerosis	2.19e-05	0.000391	CcSEcCtD
Prednisolone—CYP2A6—Biological oxidations—CYP27B1—multiple sclerosis	2.18e-05	0.00786	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—CYP24A1—multiple sclerosis	2.18e-05	0.00786	CbGpPWpGaD
Prednisolone—Conjunctivitis—Triamcinolone—multiple sclerosis	2.18e-05	0.00039	CcSEcCtD
Prednisolone—Mood swings—Prednisone—multiple sclerosis	2.18e-05	0.00039	CcSEcCtD
Prednisolone—SLCO1A2—Bile acid and bile salt metabolism—ALB—multiple sclerosis	2.17e-05	0.00783	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Mitoxantrone—multiple sclerosis	2.16e-05	0.000386	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—PTBP1—multiple sclerosis	2.14e-05	0.00772	CbGpPWpGaD
Prednisolone—Hypersensitivity—Cladribine—multiple sclerosis	2.12e-05	0.00038	CcSEcCtD
Prednisolone—Dry skin—Prednisone—multiple sclerosis	2.11e-05	0.000377	CcSEcCtD
Prednisolone—Malaise—Mitoxantrone—multiple sclerosis	2.09e-05	0.000375	CcSEcCtD
Prednisolone—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	2.09e-05	0.00754	CbGpPWpGaD
Prednisolone—SLCO1A2—Transport of vitamins, nucleosides, and related molecules—ALB—multiple sclerosis	2.08e-05	0.0075	CbGpPWpGaD
Prednisolone—Weight increased—Dexamethasone—multiple sclerosis	2.08e-05	0.000372	CcSEcCtD
Prednisolone—Weight increased—Betamethasone—multiple sclerosis	2.08e-05	0.000372	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—C4A—multiple sclerosis	2.06e-05	0.00741	CbGpPWpGaD
Prednisolone—Bradycardia—Triamcinolone—multiple sclerosis	2.05e-05	0.000367	CcSEcCtD
Prednisolone—Bradycardia—Methylprednisolone—multiple sclerosis	2.04e-05	0.000366	CcSEcCtD
Prednisolone—Muscular weakness—Prednisone—multiple sclerosis	2.03e-05	0.000363	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—multiple sclerosis	2.03e-05	0.000363	CcSEcCtD
Prednisolone—Haemoglobin—Triamcinolone—multiple sclerosis	2.02e-05	0.000362	CcSEcCtD
Prednisolone—Haemoglobin—Methylprednisolone—multiple sclerosis	2.02e-05	0.000361	CcSEcCtD
Prednisolone—Haemorrhage—Triamcinolone—multiple sclerosis	2.01e-05	0.00036	CcSEcCtD
Prednisolone—Convulsion—Mitoxantrone—multiple sclerosis	2.01e-05	0.00036	CcSEcCtD
Prednisolone—Haemorrhage—Methylprednisolone—multiple sclerosis	2.01e-05	0.000359	CcSEcCtD
Prednisolone—Acute coronary syndrome—Dexamethasone—multiple sclerosis	2.01e-05	0.000359	CcSEcCtD
Prednisolone—Acute coronary syndrome—Betamethasone—multiple sclerosis	2.01e-05	0.000359	CcSEcCtD
Prednisolone—Hypertension—Mitoxantrone—multiple sclerosis	2.01e-05	0.000359	CcSEcCtD
Prednisolone—Abdominal distension—Prednisone—multiple sclerosis	2e-05	0.000358	CcSEcCtD
Prednisolone—Myocardial infarction—Betamethasone—multiple sclerosis	1.99e-05	0.000357	CcSEcCtD
Prednisolone—Neuropathy peripheral—Dexamethasone—multiple sclerosis	1.99e-05	0.000357	CcSEcCtD
Prednisolone—Myocardial infarction—Dexamethasone—multiple sclerosis	1.99e-05	0.000357	CcSEcCtD
Prednisolone—Neuropathy peripheral—Betamethasone—multiple sclerosis	1.99e-05	0.000357	CcSEcCtD
Prednisolone—ABCB1—nervous system—multiple sclerosis	1.99e-05	0.00829	CbGeAlD
Prednisolone—Anaphylactoid reaction—Methotrexate—multiple sclerosis	1.99e-05	0.000355	CcSEcCtD
Prednisolone—Conjunctivitis—Dexamethasone—multiple sclerosis	1.98e-05	0.000354	CcSEcCtD
Prednisolone—Conjunctivitis—Betamethasone—multiple sclerosis	1.98e-05	0.000354	CcSEcCtD
Prednisolone—Discomfort—Mitoxantrone—multiple sclerosis	1.95e-05	0.00035	CcSEcCtD
Prednisolone—Pancreatitis—Prednisone—multiple sclerosis	1.95e-05	0.000349	CcSEcCtD
Prednisolone—Sweating increased—Prednisone—multiple sclerosis	1.94e-05	0.000346	CcSEcCtD
Prednisolone—Visual impairment—Methylprednisolone—multiple sclerosis	1.94e-05	0.000346	CcSEcCtD
Prednisolone—Feeling abnormal—Azathioprine—multiple sclerosis	1.93e-05	0.000346	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—multiple sclerosis	1.92e-05	0.000344	CcSEcCtD
Prednisolone—ABCB1—central nervous system—multiple sclerosis	1.91e-05	0.00798	CbGeAlD
Prednisolone—Dizziness—Cladribine—multiple sclerosis	1.91e-05	0.000341	CcSEcCtD
Prednisolone—Anaphylactic shock—Mitoxantrone—multiple sclerosis	1.9e-05	0.000339	CcSEcCtD
Prednisolone—Oedema—Mitoxantrone—multiple sclerosis	1.9e-05	0.000339	CcSEcCtD
Prednisolone—ABCB1—cerebellum—multiple sclerosis	1.87e-05	0.0078	CbGeAlD
Prednisolone—Shock—Mitoxantrone—multiple sclerosis	1.86e-05	0.000334	CcSEcCtD
Prednisolone—Bradycardia—Betamethasone—multiple sclerosis	1.86e-05	0.000333	CcSEcCtD
Prednisolone—Bradycardia—Dexamethasone—multiple sclerosis	1.86e-05	0.000333	CcSEcCtD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	1.86e-05	0.00669	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	1.86e-05	0.00669	CbGpPWpGaD
Prednisolone—Tachycardia—Mitoxantrone—multiple sclerosis	1.85e-05	0.000331	CcSEcCtD
Prednisolone—Haemoglobin—Dexamethasone—multiple sclerosis	1.84e-05	0.000328	CcSEcCtD
Prednisolone—Haemoglobin—Betamethasone—multiple sclerosis	1.84e-05	0.000328	CcSEcCtD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	1.83e-05	0.00661	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	1.83e-05	0.00661	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Mitoxantrone—multiple sclerosis	1.83e-05	0.000328	CcSEcCtD
Prednisolone—Haemorrhage—Dexamethasone—multiple sclerosis	1.83e-05	0.000327	CcSEcCtD
Prednisolone—Haemorrhage—Betamethasone—multiple sclerosis	1.83e-05	0.000327	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—multiple sclerosis	1.82e-05	0.000326	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	1.82e-05	0.00656	CbGpPWpGaD
Prednisolone—Rash—Cladribine—multiple sclerosis	1.82e-05	0.000325	CcSEcCtD
Prednisolone—Dermatitis—Cladribine—multiple sclerosis	1.82e-05	0.000325	CcSEcCtD
Prednisolone—Prednisone—ALB—multiple sclerosis	1.82e-05	0.0814	CrCbGaD
Prednisolone—Weight increased—Prednisone—multiple sclerosis	1.81e-05	0.000324	CcSEcCtD
Prednisolone—Headache—Cladribine—multiple sclerosis	1.81e-05	0.000323	CcSEcCtD
Prednisolone—Arrhythmia—Triamcinolone—multiple sclerosis	1.8e-05	0.000322	CcSEcCtD
Prednisolone—Arrhythmia—Methylprednisolone—multiple sclerosis	1.79e-05	0.000321	CcSEcCtD
Prednisolone—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	1.79e-05	0.00646	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC30A7—multiple sclerosis	1.78e-05	0.0064	CbGpPWpGaD
Prednisolone—Visual impairment—Dexamethasone—multiple sclerosis	1.76e-05	0.000315	CcSEcCtD
Prednisolone—Visual impairment—Betamethasone—multiple sclerosis	1.76e-05	0.000315	CcSEcCtD
Prednisolone—Erythema—Triamcinolone—multiple sclerosis	1.75e-05	0.000314	CcSEcCtD
Prednisolone—Erythema—Methylprednisolone—multiple sclerosis	1.75e-05	0.000313	CcSEcCtD
Prednisolone—Acute coronary syndrome—Prednisone—multiple sclerosis	1.75e-05	0.000313	CcSEcCtD
Prednisolone—Myocardial infarction—Prednisone—multiple sclerosis	1.74e-05	0.000311	CcSEcCtD
Prednisolone—Neuropathy peripheral—Prednisone—multiple sclerosis	1.74e-05	0.000311	CcSEcCtD
Prednisolone—Hypersensitivity—Azathioprine—multiple sclerosis	1.73e-05	0.000309	CcSEcCtD
Prednisolone—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	1.71e-05	0.00617	CbGpPWpGaD
Prednisolone—Nausea—Cladribine—multiple sclerosis	1.71e-05	0.000306	CcSEcCtD
Prednisolone—Paraesthesia—Mitoxantrone—multiple sclerosis	1.7e-05	0.000305	CcSEcCtD
Prednisolone—Methyltestosterone—ALB—multiple sclerosis	1.7e-05	0.0762	CrCbGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	1.68e-05	0.00607	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL12A—multiple sclerosis	1.68e-05	0.00604	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CXCL13—multiple sclerosis	1.68e-05	0.00604	CbGpPWpGaD
Prednisolone—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	1.67e-05	0.00601	CbGpPWpGaD
Prednisolone—Arrhythmia—Dexamethasone—multiple sclerosis	1.63e-05	0.000292	CcSEcCtD
Prednisolone—Arrhythmia—Betamethasone—multiple sclerosis	1.63e-05	0.000292	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—multiple sclerosis	1.63e-05	0.000291	CcSEcCtD
Prednisolone—Ill-defined disorder—Triamcinolone—multiple sclerosis	1.63e-05	0.000291	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—HNRNPA1—multiple sclerosis	1.62e-05	0.00585	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—U2AF2—multiple sclerosis	1.62e-05	0.00585	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Methylprednisolone—multiple sclerosis	1.62e-05	0.00029	CcSEcCtD
Prednisolone—Pain—Mitoxantrone—multiple sclerosis	1.62e-05	0.00029	CcSEcCtD
Prednisolone—Bradycardia—Prednisone—multiple sclerosis	1.62e-05	0.00029	CcSEcCtD
Prednisolone—Angioedema—Triamcinolone—multiple sclerosis	1.6e-05	0.000286	CcSEcCtD
Prednisolone—Haemoglobin—Prednisone—multiple sclerosis	1.6e-05	0.000286	CcSEcCtD
Prednisolone—Angioedema—Methylprednisolone—multiple sclerosis	1.6e-05	0.000286	CcSEcCtD
Prednisolone—Haemorrhage—Prednisone—multiple sclerosis	1.59e-05	0.000285	CcSEcCtD
Prednisolone—Erythema—Betamethasone—multiple sclerosis	1.59e-05	0.000284	CcSEcCtD
Prednisolone—Erythema—Dexamethasone—multiple sclerosis	1.59e-05	0.000284	CcSEcCtD
Prednisolone—Malaise—Triamcinolone—multiple sclerosis	1.58e-05	0.000283	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	1.58e-05	0.00569	CbGpPWpGaD
Prednisolone—Malaise—Methylprednisolone—multiple sclerosis	1.58e-05	0.000282	CcSEcCtD
Prednisolone—Vertigo—Triamcinolone—multiple sclerosis	1.57e-05	0.000282	CcSEcCtD
Prednisolone—Syncope—Triamcinolone—multiple sclerosis	1.57e-05	0.000281	CcSEcCtD
Prednisolone—Vertigo—Methylprednisolone—multiple sclerosis	1.57e-05	0.000281	CcSEcCtD
Prednisolone—Syncope—Methylprednisolone—multiple sclerosis	1.57e-05	0.000281	CcSEcCtD
Prednisolone—Feeling abnormal—Mitoxantrone—multiple sclerosis	1.56e-05	0.000279	CcSEcCtD
Prednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.55e-05	0.0056	CbGpPWpGaD
Prednisolone—Dizziness—Azathioprine—multiple sclerosis	1.55e-05	0.000277	CcSEcCtD
Prednisolone—Loss of consciousness—Triamcinolone—multiple sclerosis	1.54e-05	0.000276	CcSEcCtD
Prednisolone—Loss of consciousness—Methylprednisolone—multiple sclerosis	1.54e-05	0.000275	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	1.54e-05	0.00554	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—HLA-DRA—multiple sclerosis	1.53e-05	0.0055	CbGpPWpGaD
Prednisolone—ABCB1—brain—multiple sclerosis	1.52e-05	0.00634	CbGeAlD
Prednisolone—Convulsion—Triamcinolone—multiple sclerosis	1.52e-05	0.000272	CcSEcCtD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	1.52e-05	0.00547	CbGpPWpGaD
Prednisolone—Convulsion—Methylprednisolone—multiple sclerosis	1.51e-05	0.000271	CcSEcCtD
Prednisolone—Hypertension—Triamcinolone—multiple sclerosis	1.51e-05	0.000271	CcSEcCtD
Prednisolone—Hypertension—Methylprednisolone—multiple sclerosis	1.51e-05	0.00027	CcSEcCtD
Prednisolone—Urticaria—Mitoxantrone—multiple sclerosis	1.51e-05	0.000269	CcSEcCtD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	1.51e-05	0.00543	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	1.51e-05	0.00543	CbGpPWpGaD
Prednisolone—Rash—Azathioprine—multiple sclerosis	1.48e-05	0.000265	CcSEcCtD
Prednisolone—Dermatitis—Azathioprine—multiple sclerosis	1.48e-05	0.000264	CcSEcCtD
Prednisolone—Ill-defined disorder—Betamethasone—multiple sclerosis	1.48e-05	0.000264	CcSEcCtD
Prednisolone—Ill-defined disorder—Dexamethasone—multiple sclerosis	1.48e-05	0.000264	CcSEcCtD
Prednisolone—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	1.47e-05	0.00532	CbGpPWpGaD
Prednisolone—Discomfort—Triamcinolone—multiple sclerosis	1.47e-05	0.000264	CcSEcCtD
Prednisolone—Discomfort—Methylprednisolone—multiple sclerosis	1.47e-05	0.000263	CcSEcCtD
Prednisolone—Headache—Azathioprine—multiple sclerosis	1.47e-05	0.000263	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—PGR—multiple sclerosis	1.47e-05	0.00529	CbGpPWpGaD
Prednisolone—Angioedema—Betamethasone—multiple sclerosis	1.45e-05	0.00026	CcSEcCtD
Prednisolone—Angioedema—Dexamethasone—multiple sclerosis	1.45e-05	0.00026	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	1.44e-05	0.0052	CbGpPWpGaD
Prednisolone—Conjunctivitis—Methotrexate—multiple sclerosis	1.44e-05	0.000258	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—FOXP3—multiple sclerosis	1.44e-05	0.00519	CbGpPWpGaD
Prednisolone—Malaise—Betamethasone—multiple sclerosis	1.43e-05	0.000257	CcSEcCtD
Prednisolone—Malaise—Dexamethasone—multiple sclerosis	1.43e-05	0.000257	CcSEcCtD
Prednisolone—Oedema—Triamcinolone—multiple sclerosis	1.43e-05	0.000256	CcSEcCtD
Prednisolone—Anaphylactic shock—Triamcinolone—multiple sclerosis	1.43e-05	0.000256	CcSEcCtD
Prednisolone—Vertigo—Dexamethasone—multiple sclerosis	1.43e-05	0.000256	CcSEcCtD
Prednisolone—Vertigo—Betamethasone—multiple sclerosis	1.43e-05	0.000256	CcSEcCtD
Prednisolone—Anaphylactic shock—Methylprednisolone—multiple sclerosis	1.43e-05	0.000255	CcSEcCtD
Prednisolone—Syncope—Betamethasone—multiple sclerosis	1.43e-05	0.000255	CcSEcCtD
Prednisolone—Syncope—Dexamethasone—multiple sclerosis	1.43e-05	0.000255	CcSEcCtD
Prednisolone—Arrhythmia—Prednisone—multiple sclerosis	1.42e-05	0.000254	CcSEcCtD
Prednisolone—Shock—Triamcinolone—multiple sclerosis	1.41e-05	0.000252	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	1.4e-05	0.00506	CbGpPWpGaD
Prednisolone—Shock—Methylprednisolone—multiple sclerosis	1.4e-05	0.000251	CcSEcCtD
Prednisolone—Loss of consciousness—Dexamethasone—multiple sclerosis	1.4e-05	0.00025	CcSEcCtD
Prednisolone—Loss of consciousness—Betamethasone—multiple sclerosis	1.4e-05	0.00025	CcSEcCtD
Prednisolone—Hypersensitivity—Mitoxantrone—multiple sclerosis	1.4e-05	0.00025	CcSEcCtD
Prednisolone—Tachycardia—Triamcinolone—multiple sclerosis	1.4e-05	0.00025	CcSEcCtD
Prednisolone—Nausea—Azathioprine—multiple sclerosis	1.39e-05	0.000249	CcSEcCtD
Prednisolone—Tachycardia—Methylprednisolone—multiple sclerosis	1.39e-05	0.000249	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	1.39e-05	0.00501	CbGpPWpGaD
Prednisolone—Erythema—Prednisone—multiple sclerosis	1.38e-05	0.000248	CcSEcCtD
Prednisolone—Hyperhidrosis—Triamcinolone—multiple sclerosis	1.38e-05	0.000247	CcSEcCtD
Prednisolone—Hyperhidrosis—Methylprednisolone—multiple sclerosis	1.38e-05	0.000247	CcSEcCtD
Prednisolone—Convulsion—Dexamethasone—multiple sclerosis	1.38e-05	0.000246	CcSEcCtD
Prednisolone—Convulsion—Betamethasone—multiple sclerosis	1.38e-05	0.000246	CcSEcCtD
Prednisolone—Hypertension—Betamethasone—multiple sclerosis	1.37e-05	0.000246	CcSEcCtD
Prednisolone—Hypertension—Dexamethasone—multiple sclerosis	1.37e-05	0.000246	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	1.35e-05	0.00488	CbGpPWpGaD
Prednisolone—Discomfort—Dexamethasone—multiple sclerosis	1.34e-05	0.000239	CcSEcCtD
Prednisolone—Discomfort—Betamethasone—multiple sclerosis	1.34e-05	0.000239	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—multiple sclerosis	1.34e-05	0.000239	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—multiple sclerosis	1.33e-05	0.000238	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—HLA-G—multiple sclerosis	1.31e-05	0.00471	CbGpPWpGaD
Prednisolone—Vision blurred—Prednisone—multiple sclerosis	1.3e-05	0.000233	CcSEcCtD
Prednisolone—Oedema—Dexamethasone—multiple sclerosis	1.3e-05	0.000232	CcSEcCtD
Prednisolone—Anaphylactic shock—Betamethasone—multiple sclerosis	1.3e-05	0.000232	CcSEcCtD
Prednisolone—Anaphylactic shock—Dexamethasone—multiple sclerosis	1.3e-05	0.000232	CcSEcCtD
Prednisolone—Oedema—Betamethasone—multiple sclerosis	1.3e-05	0.000232	CcSEcCtD
Prednisolone—Insomnia—Triamcinolone—multiple sclerosis	1.29e-05	0.000231	CcSEcCtD
Prednisolone—Insomnia—Methylprednisolone—multiple sclerosis	1.29e-05	0.000231	CcSEcCtD
Prednisolone—Ill-defined disorder—Prednisone—multiple sclerosis	1.28e-05	0.00023	CcSEcCtD
Prednisolone—Paraesthesia—Triamcinolone—multiple sclerosis	1.28e-05	0.00023	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—ZFP36L1—multiple sclerosis	1.28e-05	0.00463	CbGpPWpGaD
Prednisolone—Paraesthesia—Methylprednisolone—multiple sclerosis	1.28e-05	0.000229	CcSEcCtD
Prednisolone—Visual impairment—Methotrexate—multiple sclerosis	1.28e-05	0.000229	CcSEcCtD
Prednisolone—Shock—Betamethasone—multiple sclerosis	1.28e-05	0.000228	CcSEcCtD
Prednisolone—Shock—Dexamethasone—multiple sclerosis	1.28e-05	0.000228	CcSEcCtD
Prednisolone—Tachycardia—Betamethasone—multiple sclerosis	1.27e-05	0.000227	CcSEcCtD
Prednisolone—Tachycardia—Dexamethasone—multiple sclerosis	1.27e-05	0.000227	CcSEcCtD
Prednisolone—Angioedema—Prednisone—multiple sclerosis	1.27e-05	0.000226	CcSEcCtD
Prednisolone—Hyperhidrosis—Betamethasone—multiple sclerosis	1.25e-05	0.000224	CcSEcCtD
Prednisolone—Hyperhidrosis—Dexamethasone—multiple sclerosis	1.25e-05	0.000224	CcSEcCtD
Prednisolone—Malaise—Prednisone—multiple sclerosis	1.25e-05	0.000223	CcSEcCtD
Prednisolone—Vertigo—Prednisone—multiple sclerosis	1.24e-05	0.000223	CcSEcCtD
Prednisolone—Syncope—Prednisone—multiple sclerosis	1.24e-05	0.000222	CcSEcCtD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—SLC11A1—multiple sclerosis	1.24e-05	0.00447	CbGpPWpGaD
Prednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	1.22e-05	0.00441	CbGpPWpGaD
Prednisolone—Pain—Triamcinolone—multiple sclerosis	1.22e-05	0.000219	CcSEcCtD
Prednisolone—Loss of consciousness—Prednisone—multiple sclerosis	1.22e-05	0.000218	CcSEcCtD
Prednisolone—Convulsion—Prednisone—multiple sclerosis	1.2e-05	0.000215	CcSEcCtD
Prednisolone—Hypertension—Prednisone—multiple sclerosis	1.2e-05	0.000214	CcSEcCtD
Prednisolone—Rash—Mitoxantrone—multiple sclerosis	1.2e-05	0.000214	CcSEcCtD
Prednisolone—Dermatitis—Mitoxantrone—multiple sclerosis	1.19e-05	0.000214	CcSEcCtD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	1.19e-05	0.00429	CbGpPWpGaD
Prednisolone—Headache—Mitoxantrone—multiple sclerosis	1.19e-05	0.000212	CcSEcCtD
Prednisolone—Feeling abnormal—Triamcinolone—multiple sclerosis	1.18e-05	0.000211	CcSEcCtD
Prednisolone—Feeling abnormal—Methylprednisolone—multiple sclerosis	1.18e-05	0.00021	CcSEcCtD
Prednisolone—Insomnia—Betamethasone—multiple sclerosis	1.17e-05	0.00021	CcSEcCtD
Prednisolone—Insomnia—Dexamethasone—multiple sclerosis	1.17e-05	0.00021	CcSEcCtD
Prednisolone—Paraesthesia—Dexamethasone—multiple sclerosis	1.17e-05	0.000208	CcSEcCtD
Prednisolone—Paraesthesia—Betamethasone—multiple sclerosis	1.17e-05	0.000208	CcSEcCtD
Prednisolone—Discomfort—Prednisone—multiple sclerosis	1.16e-05	0.000208	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.16e-05	0.0042	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.16e-05	0.0042	CbGpPWpGaD
Prednisolone—Erythema—Methotrexate—multiple sclerosis	1.16e-05	0.000207	CcSEcCtD
Prednisolone—CYP2A6—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.14e-05	0.00411	CbGpPWpGaD
Prednisolone—Urticaria—Triamcinolone—multiple sclerosis	1.14e-05	0.000203	CcSEcCtD
Prednisolone—Urticaria—Methylprednisolone—multiple sclerosis	1.13e-05	0.000203	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—IL17A—multiple sclerosis	1.13e-05	0.00408	CbGpPWpGaD
Prednisolone—Oedema—Prednisone—multiple sclerosis	1.13e-05	0.000202	CcSEcCtD
Prednisolone—Anaphylactic shock—Prednisone—multiple sclerosis	1.13e-05	0.000202	CcSEcCtD
Prednisolone—Nausea—Mitoxantrone—multiple sclerosis	1.13e-05	0.000201	CcSEcCtD
Prednisolone—Shock—Prednisone—multiple sclerosis	1.11e-05	0.000199	CcSEcCtD
Prednisolone—Pain—Dexamethasone—multiple sclerosis	1.11e-05	0.000199	CcSEcCtD
Prednisolone—Pain—Betamethasone—multiple sclerosis	1.11e-05	0.000199	CcSEcCtD
Prednisolone—Tachycardia—Prednisone—multiple sclerosis	1.1e-05	0.000197	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—CD28—multiple sclerosis	1.1e-05	0.00397	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Prednisone—multiple sclerosis	1.09e-05	0.000195	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	1.09e-05	0.00394	CbGpPWpGaD
Prednisolone—Vision blurred—Methotrexate—multiple sclerosis	1.09e-05	0.000195	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	1.08e-05	0.00387	CbGpPWpGaD
Prednisolone—Ill-defined disorder—Methotrexate—multiple sclerosis	1.07e-05	0.000192	CcSEcCtD
Prednisolone—Feeling abnormal—Betamethasone—multiple sclerosis	1.07e-05	0.000191	CcSEcCtD
Prednisolone—Feeling abnormal—Dexamethasone—multiple sclerosis	1.07e-05	0.000191	CcSEcCtD
Prednisolone—Hypersensitivity—Triamcinolone—multiple sclerosis	1.05e-05	0.000189	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—IL12B—multiple sclerosis	1.05e-05	0.0038	CbGpPWpGaD
Prednisolone—Hypersensitivity—Methylprednisolone—multiple sclerosis	1.05e-05	0.000188	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—HLA-DPB1—multiple sclerosis	1.04e-05	0.00376	CbGpPWpGaD
Prednisolone—Malaise—Methotrexate—multiple sclerosis	1.04e-05	0.000187	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—multiple sclerosis	1.04e-05	0.000186	CcSEcCtD
Prednisolone—Urticaria—Dexamethasone—multiple sclerosis	1.03e-05	0.000184	CcSEcCtD
Prednisolone—Urticaria—Betamethasone—multiple sclerosis	1.03e-05	0.000184	CcSEcCtD
Prednisolone—NR3C2—Generic Transcription Pathway—VDR—multiple sclerosis	1.03e-05	0.0037	CbGpPWpGaD
Prednisolone—Insomnia—Prednisone—multiple sclerosis	1.02e-05	0.000183	CcSEcCtD
Prednisolone—Paraesthesia—Prednisone—multiple sclerosis	1.01e-05	0.000182	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—CD40—multiple sclerosis	1e-05	0.00362	CbGpPWpGaD
Prednisolone—Convulsion—Methotrexate—multiple sclerosis	1e-05	0.000179	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—PABPC1—multiple sclerosis	9.95e-06	0.00359	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CTLA4—multiple sclerosis	9.9e-06	0.00357	CbGpPWpGaD
Prednisolone—Testosterone—ALB—multiple sclerosis	9.86e-06	0.0442	CrCbGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	9.83e-06	0.00354	CbGpPWpGaD
Prednisolone—Discomfort—Methotrexate—multiple sclerosis	9.73e-06	0.000174	CcSEcCtD
Prednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	9.57e-06	0.00345	CbGpPWpGaD
Prednisolone—Dizziness—Triamcinolone—multiple sclerosis	9.46e-06	0.000169	CcSEcCtD
Prednisolone—Anaphylactic shock—Methotrexate—multiple sclerosis	9.44e-06	0.000169	CcSEcCtD
Prednisolone—Dizziness—Methylprednisolone—multiple sclerosis	9.44e-06	0.000169	CcSEcCtD
Prednisolone—Feeling abnormal—Prednisone—multiple sclerosis	9.31e-06	0.000167	CcSEcCtD
Prednisolone—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	9.28e-06	0.00335	CbGpPWpGaD
Prednisolone—CYP2A6—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	9.24e-06	0.00333	CbGpPWpGaD
Prednisolone—Hyperhidrosis—Methotrexate—multiple sclerosis	9.13e-06	0.000163	CcSEcCtD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	9.05e-06	0.00326	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	9.03e-06	0.00325	CbGpPWpGaD
Prednisolone—Rash—Triamcinolone—multiple sclerosis	9.02e-06	0.000161	CcSEcCtD
Prednisolone—Dermatitis—Triamcinolone—multiple sclerosis	9.01e-06	0.000161	CcSEcCtD
Prednisolone—Rash—Methylprednisolone—multiple sclerosis	9e-06	0.000161	CcSEcCtD
Prednisolone—Dermatitis—Methylprednisolone—multiple sclerosis	8.99e-06	0.000161	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—RPL5—multiple sclerosis	8.98e-06	0.00324	CbGpPWpGaD
Prednisolone—Urticaria—Prednisone—multiple sclerosis	8.98e-06	0.000161	CcSEcCtD
Prednisolone—Headache—Triamcinolone—multiple sclerosis	8.96e-06	0.00016	CcSEcCtD
Prednisolone—Headache—Methylprednisolone—multiple sclerosis	8.94e-06	0.00016	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—HLA-DQA1—multiple sclerosis	8.72e-06	0.00314	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	8.71e-06	0.00314	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—FAS—multiple sclerosis	8.63e-06	0.00311	CbGpPWpGaD
Prednisolone—Dizziness—Betamethasone—multiple sclerosis	8.58e-06	0.000154	CcSEcCtD
Prednisolone—Dizziness—Dexamethasone—multiple sclerosis	8.58e-06	0.000154	CcSEcCtD
Prednisolone—Insomnia—Methotrexate—multiple sclerosis	8.54e-06	0.000153	CcSEcCtD
Prednisolone—Nausea—Triamcinolone—multiple sclerosis	8.49e-06	0.000152	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—multiple sclerosis	8.48e-06	0.000152	CcSEcCtD
Prednisolone—Nausea—Methylprednisolone—multiple sclerosis	8.48e-06	0.000152	CcSEcCtD
Prednisolone—Hypersensitivity—Prednisone—multiple sclerosis	8.33e-06	0.000149	CcSEcCtD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	8.32e-06	0.003	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	8.25e-06	0.00297	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ZNF746—multiple sclerosis	8.25e-06	0.00297	CbGpPWpGaD
Prednisolone—Rash—Dexamethasone—multiple sclerosis	8.18e-06	0.000146	CcSEcCtD
Prednisolone—Rash—Betamethasone—multiple sclerosis	8.18e-06	0.000146	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	8.18e-06	0.00295	CbGpPWpGaD
Prednisolone—Dermatitis—Dexamethasone—multiple sclerosis	8.17e-06	0.000146	CcSEcCtD
Prednisolone—Dermatitis—Betamethasone—multiple sclerosis	8.17e-06	0.000146	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—HLA-DQB1—multiple sclerosis	8.15e-06	0.00294	CbGpPWpGaD
Prednisolone—Headache—Betamethasone—multiple sclerosis	8.13e-06	0.000145	CcSEcCtD
Prednisolone—Headache—Dexamethasone—multiple sclerosis	8.13e-06	0.000145	CcSEcCtD
Prednisolone—Pain—Methotrexate—multiple sclerosis	8.08e-06	0.000145	CcSEcCtD
Prednisolone—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	8e-06	0.00288	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	8e-06	0.00288	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	7.89e-06	0.00284	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	7.89e-06	0.00284	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CD86—multiple sclerosis	7.85e-06	0.00283	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	7.81e-06	0.00281	CbGpPWpGaD
Prednisolone—Feeling abnormal—Methotrexate—multiple sclerosis	7.78e-06	0.000139	CcSEcCtD
Prednisolone—Nausea—Dexamethasone—multiple sclerosis	7.71e-06	0.000138	CcSEcCtD
Prednisolone—Nausea—Betamethasone—multiple sclerosis	7.71e-06	0.000138	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—IL10—multiple sclerosis	7.7e-06	0.00277	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CD40LG—multiple sclerosis	7.7e-06	0.00277	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PTBP1—multiple sclerosis	7.54e-06	0.00272	CbGpPWpGaD
Prednisolone—Urticaria—Methotrexate—multiple sclerosis	7.5e-06	0.000134	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—IL4—multiple sclerosis	7.49e-06	0.0027	CbGpPWpGaD
Prednisolone—Dizziness—Prednisone—multiple sclerosis	7.47e-06	0.000134	CcSEcCtD
Prednisolone—SLCO1A2—Metabolism—SRM—multiple sclerosis	7.36e-06	0.00265	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—HLA-B—multiple sclerosis	7.32e-06	0.00264	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	7.27e-06	0.00262	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—AQP4—multiple sclerosis	7.14e-06	0.00257	CbGpPWpGaD
Prednisolone—Rash—Prednisone—multiple sclerosis	7.13e-06	0.000127	CcSEcCtD
Prednisolone—Dermatitis—Prednisone—multiple sclerosis	7.12e-06	0.000127	CcSEcCtD
Prednisolone—Headache—Prednisone—multiple sclerosis	7.08e-06	0.000127	CcSEcCtD
Prednisolone—NR3C2—Gene Expression—PGR—multiple sclerosis	7.07e-06	0.00255	CbGpPWpGaD
Prednisolone—Hypersensitivity—Methotrexate—multiple sclerosis	6.96e-06	0.000125	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—FAS—multiple sclerosis	6.9e-06	0.00249	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL2RA—multiple sclerosis	6.86e-06	0.00247	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—HLA-A—multiple sclerosis	6.79e-06	0.00245	CbGpPWpGaD
Prednisolone—Nausea—Prednisone—multiple sclerosis	6.71e-06	0.00012	CcSEcCtD
Prednisolone—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	6.59e-06	0.00237	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	6.45e-06	0.00232	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	6.43e-06	0.00232	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	6.31e-06	0.00227	CbGpPWpGaD
Prednisolone—Dizziness—Methotrexate—multiple sclerosis	6.25e-06	0.000112	CcSEcCtD
Prednisolone—ABCB1—Allograft Rejection—HLA-DRB1—multiple sclerosis	6.2e-06	0.00223	CbGpPWpGaD
Prednisolone—Rash—Methotrexate—multiple sclerosis	5.95e-06	0.000107	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—multiple sclerosis	5.95e-06	0.000106	CcSEcCtD
Prednisolone—Headache—Methotrexate—multiple sclerosis	5.92e-06	0.000106	CcSEcCtD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	5.74e-06	0.00207	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—CD80—multiple sclerosis	5.73e-06	0.00206	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	5.72e-06	0.00206	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—U2AF2—multiple sclerosis	5.72e-06	0.00206	CbGpPWpGaD
Prednisolone—Nausea—Methotrexate—multiple sclerosis	5.61e-06	0.0001	CcSEcCtD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	5.56e-06	0.002	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SRM—multiple sclerosis	5.3e-06	0.00191	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP24A1—multiple sclerosis	5.19e-06	0.00187	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP27B1—multiple sclerosis	5.19e-06	0.00187	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	5.17e-06	0.00186	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC15A2—multiple sclerosis	5.1e-06	0.00184	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	5.07e-06	0.00183	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	4.96e-06	0.00179	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—VDR—multiple sclerosis	4.94e-06	0.00178	CbGpPWpGaD
Prednisolone—CYP2A6—Biological oxidations—POMC—multiple sclerosis	4.91e-06	0.00177	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	4.85e-06	0.00175	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GPC5—multiple sclerosis	4.74e-06	0.00171	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—multiple sclerosis	4.61e-06	0.00166	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IFNG—multiple sclerosis	4.53e-06	0.00163	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	4.52e-06	0.00163	CbGpPWpGaD
Prednisolone—SLCO1A2—SLC-mediated transmembrane transport—ALB—multiple sclerosis	4.47e-06	0.00161	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	4.36e-06	0.00157	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	4.27e-06	0.00154	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—STAT3—multiple sclerosis	4.23e-06	0.00152	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	4.18e-06	0.00151	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—multiple sclerosis	4.08e-06	0.00147	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL1B—multiple sclerosis	4.04e-06	0.00146	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—IL2—multiple sclerosis	4.02e-06	0.00145	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	3.98e-06	0.00143	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—RRM1—multiple sclerosis	3.93e-06	0.00142	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	3.92e-06	0.00141	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC30A7—multiple sclerosis	3.86e-06	0.00139	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP27B1—multiple sclerosis	3.73e-06	0.00134	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP24A1—multiple sclerosis	3.73e-06	0.00134	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—TNF—multiple sclerosis	3.66e-06	0.00132	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	3.61e-06	0.0013	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PABPC1—multiple sclerosis	3.5e-06	0.00126	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GPC5—multiple sclerosis	3.41e-06	0.00123	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	3.41e-06	0.00123	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	3.39e-06	0.00122	CbGpPWpGaD
Prednisolone—CYP2A6—NRF2 pathway—TGFB1—multiple sclerosis	3.23e-06	0.00116	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	3.16e-06	0.00114	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—RPL5—multiple sclerosis	3.16e-06	0.00114	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SRM—multiple sclerosis	3.15e-06	0.00114	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TGFB1—multiple sclerosis	3.14e-06	0.00113	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—AQP4—multiple sclerosis	3.05e-06	0.0011	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	3.05e-06	0.0011	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—IL6—multiple sclerosis	2.96e-06	0.00107	CbGpPWpGaD
Prednisolone—ABCB1—Allograft Rejection—TNF—multiple sclerosis	2.93e-06	0.00106	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—RRM1—multiple sclerosis	2.83e-06	0.00102	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC11A1—multiple sclerosis	2.7e-06	0.000973	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.62e-06	0.000944	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	2.55e-06	0.000921	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PGR—multiple sclerosis	2.49e-06	0.000897	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.39e-06	0.000861	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.27e-06	0.000818	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—BCHE—multiple sclerosis	2.26e-06	0.000814	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP27B1—multiple sclerosis	2.22e-06	0.0008	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP24A1—multiple sclerosis	2.22e-06	0.0008	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GPC5—multiple sclerosis	2.03e-06	0.000732	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—multiple sclerosis	1.96e-06	0.000708	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SRM—multiple sclerosis	1.94e-06	0.0007	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—POMC—multiple sclerosis	1.8e-06	0.000648	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—VDR—multiple sclerosis	1.74e-06	0.000627	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—RRM1—multiple sclerosis	1.68e-06	0.000606	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—BCHE—multiple sclerosis	1.62e-06	0.000585	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	1.55e-06	0.00056	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	1.55e-06	0.000558	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	1.52e-06	0.000547	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	1.45e-06	0.000521	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	1.44e-06	0.000517	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	1.37e-06	0.000493	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	1.37e-06	0.000493	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—APOE—multiple sclerosis	1.36e-06	0.000489	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GPC5—multiple sclerosis	1.25e-06	0.000451	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—POMC—multiple sclerosis	1.17e-06	0.00042	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ALB—multiple sclerosis	1.06e-06	0.000383	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—RRM1—multiple sclerosis	1.04e-06	0.000374	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—APOE—multiple sclerosis	9.77e-07	0.000352	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ALB—multiple sclerosis	9.72e-07	0.00035	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—BCHE—multiple sclerosis	9.66e-07	0.000348	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—POMC—multiple sclerosis	8.39e-07	0.000302	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ALB—multiple sclerosis	7.65e-07	0.000276	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—multiple sclerosis	6.91e-07	0.000249	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—BCHE—multiple sclerosis	5.95e-07	0.000215	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—APOE—multiple sclerosis	5.81e-07	0.00021	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—POMC—multiple sclerosis	4.99e-07	0.00018	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ALB—multiple sclerosis	4.55e-07	0.000164	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—APOE—multiple sclerosis	3.58e-07	0.000129	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—POMC—multiple sclerosis	3.08e-07	0.000111	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ALB—multiple sclerosis	2.81e-07	0.000101	CbGpPWpGaD
